Quantitative Investment Management LLC boosted its stake in Baxter International Inc. (NYSE:BAX) by 78.3% during the third quarter, Holdings Channel reports. The firm owned 109,300 shares of the company’s stock after buying an additional 48,000 shares during the period. Quantitative Investment Management LLC’s holdings in Baxter International were worth $5,202,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of BAX. Balentine LLC boosted its position in Baxter International by 12.6% in the second quarter. Balentine LLC now owns 3,176 shares of the company’s stock valued at $144,000 after buying an additional 356 shares during the period. SignalPoint Asset Management LLC bought a new position in shares of Baxter International during the second quarter valued at about $214,000. Stonebridge Capital Advisors LLC bought a new position in shares of Baxter International during the second quarter valued at about $215,000. SevenBridge Financial Group LLC bought a new position in shares of Baxter International during the second quarter valued at about $216,000. Finally, Community Financial Services Group LLC bought a new position in shares of Baxter International during the second quarter valued at about $224,000. Institutional investors own 83.66% of the company’s stock.
Shares of Baxter International Inc. (NYSE:BAX) opened at 47.08 on Friday. The firm has a market cap of $25.61 billion, a PE ratio of 5.27 and a beta of 0.82. The company’s 50-day moving average is $45.38 and its 200-day moving average is $46.65. Baxter International Inc. has a 52 week low of $35.54 and a 52 week high of $50.16.
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, January 3rd. Stockholders of record on Friday, December 2nd were paid a dividend of $0.13 per share. The ex-dividend date of this dividend was Wednesday, November 30th. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.10%. Baxter International’s dividend payout ratio is currently 5.83%.
Several brokerages have recently issued reports on BAX. Zacks Investment Research cut shares of Baxter International from a “hold” rating to a “sell” rating in a report on Tuesday, January 17th. RBC Capital Markets restated a “sector perform” rating and issued a $55.00 target price (up previously from $50.00) on shares of Baxter International in a report on Wednesday, October 26th. Evercore ISI restated a “buy” rating and issued a $56.00 target price (up previously from $52.00) on shares of Baxter International in a report on Wednesday, October 26th. Royal Bank Of Canada upped their target price on shares of Baxter International from $50.00 to $55.00 and gave the company a “sector perform” rating in a report on Wednesday, October 26th. Finally, Wells Fargo & Company began coverage on shares of Baxter International in a report on Thursday, October 13th. They issued an “outperform” rating for the company. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $51.30.
Baxter International Company Profile
Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX).